{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:46:06Z","timestamp":1782906366864,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T00:00:00Z","timestamp":1183939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T00:00:00Z","timestamp":1183939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/sj.bmt.1705769","type":"journal-article","created":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T13:05:11Z","timestamp":1183986311000},"page":"535-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study"],"prefix":"10.1038","volume":"40","author":[{"given":"C H","family":"Gutierrez-Aguirre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Gomez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O G","family":"Cantu-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Gonzalez-Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Jaime-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Herena-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Estrada-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Gonzalez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G J","family":"Ruiz-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,9]]},"reference":[{"key":"BF1705769_CR1","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1007\/s00277-003-0776-0","volume":"83","author":"RA Larson","year":"2004","unstructured":"Larson RA . The US Trials in adult acute lymphoblastic leukemia. Ann Hematol 2004; 83: S127\u2013S128.","journal-title":"Ann Hematol"},{"key":"BF1705769_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood.V99.3.863","volume":"99","author":"L Annino","year":"2002","unstructured":"Annino L, Vegna ML, Camera A, Specchia G, Visan G, Fioritoni G et al. Treatment of acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863\u2013871.","journal-title":"Blood"},{"key":"BF1705769_CR3","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia : analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075\u20134086.","journal-title":"J Clin Oncol"},{"key":"BF1705769_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE . Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166\u2013178.","journal-title":"N Engl J Med"},{"key":"BF1705769_CR5","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1182\/blood-2003-10-3560","volume":"104","author":"M Hunault","year":"2004","unstructured":"Hunault M, Horousseau JL, Delain M, Truchan-Graczy KM, Cahn JY, Witz F et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS Trial. Blood 2004; 104: 3028\u20133037.","journal-title":"Blood"},{"key":"BF1705769_CR6","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA MC Sweeney","year":"2001","unstructured":"MC Sweeney PA, Niderwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematological malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effect. Blood 2001; 97: 3390\u20133399.","journal-title":"Blood"},{"key":"BF1705769_CR7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood.V71.3.723.723","volume":"71","author":"A Kessinger","year":"1998","unstructured":"Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD . Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1998; 71: 723\u2013727.","journal-title":"Blood"},{"key":"BF1705769_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.bmt.1702100","volume":"25","author":"D G\u00f3mez-Almaguer","year":"2000","unstructured":"G\u00f3mez-Almaguer D, Ruiz-Arg\u00fcelles GJ, Ruiz-Arg\u00fcelles A, Gonz\u00e1lez-Llano O, Cant\u00fa OE, Hern\u00e1ndez NE . Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transplant 2000; 25: 131\u2013133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705769_CR9","first-page":"894","volume":"87","author":"GJ Ruiz-Arg\u00fcelles","year":"2002","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, L\u00f3pez-Mart\u00ednez B, Cant\u00fa-Rodr\u00edguez OG, Jaime-P\u00e9rez JC, Gonz\u00e1lez-Llano O . Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 2002; 87: 894\u2013896.","journal-title":"Haematologica"},{"key":"BF1705769_CR10","first-page":"735","volume":"50","author":"A Ruiz-Arg\u00fcelles","year":"1992","unstructured":"Ruiz-Arg\u00fcelles A . Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992; 50: 735\u2013743.","journal-title":"Ann Biol Clin"},{"key":"BF1705769_CR11","first-page":"79","volume-title":"Actualizaci\u00f3n en Leucemias. Editorial M\u00e9dica Panamericana","author":"A Ruiz-Arg\u00fcelles","year":"1996","unstructured":"Ruiz-Arg\u00fcelles A, Orfao A . Caracterizaci\u00f3n y evaluaci\u00f3n de c\u00e9lulas totipotenciales en sangre perif\u00e9rica y m\u00e9dula \u00f3sea. In: Ruiz-Arg\u00fcelles GJ, San-Miguel JF (eds). Actualizaci\u00f3n en Leucemias. Editorial M\u00e9dica Panamericana. M\u00e9xico City, 1996, pp 79\u201382."},{"key":"BF1705769_CR12","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rond\u00f3n G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF1705769_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00007890-198703000-00016","volume":"43","author":"P Yam","year":"1987","unstructured":"Yam P, Petz L, Knowlton R, Wallace R, Stock A, deLange G et al. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 1987; 43: 399\u2013407.","journal-title":"Transplantation"},{"key":"BF1705769_CR14","first-page":"118","volume":"52","author":"GJ Ruiz-Arg\u00fcelles","year":"2000","unstructured":"Ruiz-Arg\u00fcelles GJ, Garc\u00e9s-Eisele J, Reyes-N\u00fa\u00f1ez V, P\u00e9rez-Romano B, Ruiz-Arg\u00fcelles A, Ram\u00edrez-Cisneros F et al. Assessment of residual disease in acute leukemia by means of polymerase chain reaction: a prospective study in a single institution. Rev Invest Clin Mex 2000; 52: 118\u2013124.","journal-title":"Rev Invest Clin Mex"},{"key":"BF1705769_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","volume":"9","author":"K Doney","year":"2003","unstructured":"Doney K, H\u00e4gglund H, Leisenring W, Chauncey T, Appelbaum FR, Storb R . Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2003; 9: 472\u2013481.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705769_CR16","first-page":"2","volume":"108","author":"JM Rowe","year":"2006","unstructured":"Rowe JM, Buck G, Fielding A, Tallman MS, Burnett AK, Chopra R et al. In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from an allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation\/maintenance chemotherapy: final results of the international ALL trial (MRC UKALL XII\/ECOG E2993). Blood (ASH Annual Meeting Abstracts) 2006; 108: 2.","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"BF1705769_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<534::AID-MPO3>3.0.CO;2-L","volume":"29","author":"SA Feig","year":"1997","unstructured":"Feig SA, Harris RE, Sather HN . Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the children's cancer group (CCG-1884). Med Pediatr Oncol 1997; 29: 534\u2013540.","journal-title":"Med Pediatr Oncol"},{"key":"BF1705769_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1200\/JCO.1999.17.1.197","volume":"17","author":"F Boulad","year":"1999","unstructured":"Boulad F, Steinherz P, Reys B, Heller G, Gillio AP, Small TN et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. J Clin Oncol 1999; 17: 197\u2013207.","journal-title":"J Clin Oncol"},{"key":"BF1705769_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2141.1997.d01-2033.x","volume":"96","author":"C Uderzo","year":"1997","unstructured":"Uderzo C, Valsecchi MG, Balduzzi A . Allogeneic bone marrow transplantation versus chemotherapy in high risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di ematologia ed oncologia pediatrica (AIEOP) and the gruppo Italiano trapianto di midollo osseo (GITMO). Br J Haematol 1997; 96: 387\u2013394.","journal-title":"Br J Haematol"},{"key":"BF1705769_CR20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V78.5.1166.1166","volume":"78","author":"G Henze","year":"1991","unstructured":"Henze G, Fengler R, Hartmann R . Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85): a relapse study of the BFM group. Blood 1991; 78: 1162\u20131172.","journal-title":"Blood"},{"key":"BF1705769_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.bmt.1702100","volume":"25","author":"D G\u00f3mez-Almaguer","year":"2000","unstructured":"G\u00f3mez-Almaguer D, Ruiz-Arg\u00fcelles GJ, Ruiz-Arg\u00fcelles A, Gonz\u00e1lez-Llano O, Cant\u00fa OE, Hern\u00e1ndez NE . Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transplant 2000; 25: 131\u2013133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705769_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.bmt.1705190","volume":"36","author":"GJ Ruiz-Arg\u00fcelles","year":"2005","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, Morales-Toquero A, Guti\u00e9rrez-Aguirre CH, Vela-Ojeda J, Garc\u00eda-Ruiz-Esparza M et al. The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study. Bone Marrow Transplant 2005; 36: 1043\u20131047.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705769_CR23","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood.V98.6.1982","volume":"98","author":"M Uzunel","year":"2001","unstructured":"Uzunel M, Mattsson J, Jaksch M, Remberger M, Ringden O . The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood 2001; 98: 1982\u20131985.","journal-title":"Blood"},{"key":"BF1705769_CR24","first-page":"921","volume":"18","author":"O Ringden","year":"1996","unstructured":"Ringden O, Labopin M, Gluckman E . Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined witn methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 18: 921\u2013929.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705769_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1705769_CR26","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/10428190310001642846","volume":"45","author":"GJ Ruiz-Arg\u00fcelles","year":"2004","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, G\u00f3mez Rangel JD, Vela-Ojeda J, Cant\u00fa-Rodr\u00edguez OG, Jaime-P\u00e9rez JC et al. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: a prospective study. Leuk Lymphoma 2004; 45: 1191\u20131195.","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 1","key":"BF1705769_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/10245330512331390258","volume":"10","author":"GJ Ruiz-Arg\u00fcelles","year":"2005","unstructured":"Ruiz-Arg\u00fcelles GJ . The Mexican approach to conduct allogeneic stem cell transplantation: breaking dogmata and facing the Matthew effect. Hematology 2005; 10 (Suppl 1): 154\u2013160.","journal-title":"Hematology"},{"key":"BF1705769_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1532\/IJH97.04195","volume":"82","author":"GJ Ruiz-Arg\u00fcelles","year":"2005","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, Vela-Ojeda J, Morales-Toquero A, G\u00f3mez-Rangel JD, Garc\u00eda-Ruiz-Esparza MA et al. Extramedullary leukemic relapses following hematopoietic stem cell transplantation with non-myeloablative conditioning. Int J Hematol 2005; 82: 262\u2013265.","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"BF1705769_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/BF03165288","volume":"76","author":"D Gomez-Almaguer","year":"2002","unstructured":"Gomez-Almaguer D . The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients. Int J Hematol 2002; 76 (Suppl 1): 380\u2013382.","journal-title":"Int J Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705769","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:44:52Z","timestamp":1648082692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,9]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF1705769"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705769","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,9]]},"assertion":[{"value":"11 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}